Stocks March: Two Compelling Buys for March Investing
As March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesAs March rolls in, the market keeps delivering surprises. This guide highlights two prime opportunities to buy in Mar...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Wondering how to earn much while claiming Social Security without sacrificing your benefits? This guide explains the ...
Mortgage rates in early 2026 show a pause after a volatile fall and rise. This piece breaks down what buyers and inve...
The artificial intelligence (ai) trade is splitting into two distinct lanes: training and inference. This guide expla...
The mood around U.S. housing is shifting. Prices, rents, and mortgage costs are moving in ways that could change how ...
In 2026, investors face a choice between rapid disruption and steady government contracts. This article compares Spac...
A much-anticipated Las Vegas weekend fundraiser tied to Flavor Flav has people buzzing. But the real story isn’t the ...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
Ethereum faces near-term headwinds, but a rebound may follow a deeper pullback. This analysis translates Standard Cha...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...